semaglutide
Obesity Treatment Myths That Cost You Money
About 40% of U.S. adults face obesity, and the most costly myths are that GLP-1 drugs are only for extreme obesity, that they do little for weight loss, that they raise overall health expenses, and that technology offers no real benefit. Did you know that recent Medicare updates could